Lupin to acquire Symbiomix Therapeutics
The acquisition expands Lupin’s branded women’s health speciality business
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Regenerative medicine set to shake up therapy market
Regenerative medicine could produce new therapeutic interventions for cancers, genetic disorders or autoimmune diseases
Clariant launches packaging solutions for probiotics
The shelf life of probiotics in nutraceutical products is extended by inhibiting their exposure to damaging oxygen, moisture and…
Pharma exports declined by 4 per cent up to Aug on pricing pressure
Udaya Bhaskar, Director General, Pharmexcil hopes that the overall exports will recover and come into positive zone for the full…
PPS to expand API manufacturing capabilities in Asia and North America
Announces investments worth $55 million
Vice President inaugurates third International Conference on Yoga
The theme of this year’s conference will be ‘Yoga for Wellness’
Vice President, M Venkaiah Naidu inaugurated the two-day…
Marksans Pharma gets EIR from US FDA for its Goa facility
EIR is issued to a company detailing inspectional findings
Lupin receives FDA approval for generic Corgard Tablets
Nadolol Tablets are indicated for management of patients with angina pectoris and for the treatment of hypertension
Intas Pharma brings down cancer treatment cost by 60%
Bevacizumab is used in treating multiple-cancers like colorectal cancer, ovarian cancer, cervical cancer, lung cancer and…